Shell plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Shell plc, a foreign issuer incorporated in England and Wales, covers the month of July 2024. The report was filed on July 1, 2024, to disclose additional regulated information required under the laws of a Member State.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a director declaration and does not contain financial performance data.
Material Changes
The material change disclosed is the appointment of Cyrus Taraporevala, a Non-executive Director of Shell plc, to the Board of Pfizer Inc. on July 1, 2024, pursuant to Listing Rule 9.6.14R(2).
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It is strictly a notification of a director's external appointment.
Key Facts for Investors
- Director Appointment: Cyrus Taraporevala joined the Board of Pfizer Inc. on July 1, 2024.
- Regulatory Basis: Disclosure made under Listing Rule 9.6.14R(2).
- Financial Data: No financial metrics are included in this specific filing.
- Reference: This report is incorporated by reference into Shell's Registration Statements on Form F-3 and Form S-8.